34例小儿自身免疫性胶质纤维酸性蛋白星形胶质细胞病的临床特征分析

王文雯, 李梅

中国当代儿科杂志 ›› 2023, Vol. 25 ›› Issue (1) : 67-72.

PDF(698 KB)
HTML
PDF(698 KB)
HTML
中国当代儿科杂志 ›› 2023, Vol. 25 ›› Issue (1) : 67-72. DOI: 10.7499/j.issn.1008-8830.2208105
论著·临床研究

34例小儿自身免疫性胶质纤维酸性蛋白星形胶质细胞病的临床特征分析

  • 王文雯, 李梅
作者信息 +

Clinical features of autoimmune glial fibrillary acidic protein astrocytopathy in children: an analysis of 34 cases

  • WANG Wen-Wen, LI Mei
Author information +
文章历史 +

摘要

目的 分析自身免疫性胶质纤维酸性蛋白星形胶质细胞病(glial fibrillary acidic protein astrocytopathy,GFAP-A)患儿的临床特征。 方法 回顾性收集2020年1月—2022年2月于重庆医科大学附属儿童医院神经内科就诊的34例GFAP-A患儿的临床资料,对其临床表现、脑脊液特点、影像学检查、治疗及预后进行分析。 结果 34例GFAP-A患儿中位起病年龄为8.4(范围:1.9~14.9)岁。患儿主要表现为头痛(50%,17/34)、发热(47%,16/34)、视力障碍(47%,16/34)、意识障碍(44%,15/34)等。56%(19/34)患儿脑脊液检查结果异常,其中8例合并其他自身抗体阳性。重叠综合征患儿的复发率及免疫抑制剂使用率高于非重叠综合征患儿(P<0.05)。77%(24/31)患儿对免疫治疗反应好,仅1例预后不良。 结论 GFAP-A患儿临床症状无特异性,对免疫治疗反应好。其出现重叠综合征时易复发,早期应用免疫抑制剂可能预防复发和缓解疾病症状。

Abstract

Objective To study the clinical features of children with autoimmune glial fibrillary acidic protein astrocytopathy (GFAP-A). Methods A retrospective analysis was performed on the medical data of 34 children with GFAP-A who attended the Department of Neurology, Children's Hospital of Chongqing Medical University, from January 2020 to February 2022. The medical data included clinical manifestations, cerebrospinal fluid features, imaging examination results, treatment, and prognosis. Results The median age of onset was 8.4 (range 1.9-14.9) years for the 34 children with GFAP-A. The main clinical manifestations included headache (50%, 17/34), fever (47%, 16/34), visual impairment (47%, 16/34), and disturbance of consciousness (44%, 15/34). Abnormal cerebrospinal fluid results were observed in 19 children (56%, 19/34), among whom 8 children had positive autoantibody. The children with overlap syndrome had significantly higher recurrence rate and rate of use of immunosuppressant than those without overlap syndrome (P<0.05). About 77% (24/31) of the children had good response to immunotherapy, and only 1 child had poor prognosis. Conclusions Children with GFAP-A often have non-specific clinical symptoms and show good response to immunotherapy. Children with overlap syndrome have a high recurrence rate, and early application of immunosuppressants may help to prevent recurrence and alleviate symptoms.

关键词

自身免疫性胶质纤维酸性蛋白星形胶质细胞病 / 胶质纤维酸性蛋白 / 脑炎 / 儿童

Key words

Autoimmune glial fibrillary acidic protein astrocytopathy / Glial fibrillary acidic protein / Encephalitis / Child

引用本文

导出引用
王文雯, 李梅. 34例小儿自身免疫性胶质纤维酸性蛋白星形胶质细胞病的临床特征分析[J]. 中国当代儿科杂志. 2023, 25(1): 67-72 https://doi.org/10.7499/j.issn.1008-8830.2208105
WANG Wen-Wen, LI Mei. Clinical features of autoimmune glial fibrillary acidic protein astrocytopathy in children: an analysis of 34 cases[J]. Chinese Journal of Contemporary Pediatrics. 2023, 25(1): 67-72 https://doi.org/10.7499/j.issn.1008-8830.2208105

参考文献

1 Fang B, McKeon A, Hinson SR, et al. Autoimmune glial fibrillary acidic protein astrocytopathy: a novel meningoencephalomyelitis[J]. JAMA Neurol, 2016, 73(11): 1297-1307. PMID: 27618707. DOI: 10.1001/jamaneurol.2016.2549.
2 Kunchok A, Zekeridou A, McKeon A. Autoimmune glial fibrillary acidic protein astrocytopathy[J]. Curr Opin Neurol, 2019, 32(3): 452-458. PMID: 30724768. PMCID: PMC6522205. DOI: 10.1097/WCO.0000000000000676.
3 Martinez-Hernandez E, Guasp M, García-Serra A, et al. Clinical significance of anti-NMDAR concurrent with glial or neuronal surface antibodies[J]. Neurology, 2020, 94(22): e2302-e2310. PMID: 32161029. DOI: 10.1212/WNL.0000000000009239.
4 Palace J, Lin DY, Zeng D, et al. Outcome prediction models in AQP4-IgG positive neuromyelitis optica spectrum disorders[J]. Brain, 2019, 142(5): 1310-1323. PMID: 30938427. PMCID: PMC6487334. DOI: 10.1093/brain/awz054.
5 Wingerchuk DM, Banwell B, Bennett JL, et al. International consensus diagnostic criteria for neuromyelitis optica spectrum disorders[J]. Neurology, 2015, 85(2): 177-189. PMID: 26092914. PMCID: PMC4515040. DOI: 10.1212/WNL.0000000000001729.
6 Iorio R, Damato V, Evoli A, et al. Clinical and immunological characteristics of the spectrum of GFAP autoimmunity: a case series of 22 patients[J]. J Neurol Neurosurg Psychiatry, 2018, 89(2): 138-146. PMID: 28951498. DOI: 10.1136/jnnp-2017-316583.
7 Fang H, Hu W, Jiang Z, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in children: a retrospective analysis of 35 cases[J]. Front Immunol, 2021, 12: 761354. PMID: 34880859. PMCID: PMC8645641. DOI: 10.3389/fimmu.2021.761354.
8 Flanagan EP, Hinson SR, Lennon VA, et al. Glial fibrillary acidic protein immunoglobulin G as biomarker of autoimmune astrocytopathy: analysis of 102 patients[J]. Ann Neurol, 2017, 81(2): 298-309. PMID: 28120349. DOI: 10.1002/ana.24881.
9 Yang X, Liang J, Huang Q, et al. Treatment of autoimmune glial fibrillary acidic protein astrocytopathy: follow-up in 7 cases[J]. Neuroimmunomodulation, 2017, 24(2): 113-119. PMID: 28922662. DOI: 10.1159/000479948.
10 Long Y, Liang J, Xu H, et al. Autoimmune glial fibrillary acidic protein astrocytopathy in Chinese patients: a retrospective study[J]. Eur J Neurol, 2018, 25(3): 477-483. PMID: 29193473. DOI: 10.1111/ene.13531.
11 Huang Q, Yang H, Liu T, et al. Patients with suspected benign tumors and glial fibrillary acidic protein autoantibody: an analysis of five cases[J]. Int J Neurosci, 2019, 129(12): 1183-1188. PMID: 31327295. DOI: 10.1080/00207454.2019.1645140.
12 Kimura A, Takekoshi A, Yoshikura N, et al. Clinical characteristics of autoimmune GFAP astrocytopathy[J]. J Neuroimmunol, 2019, 332: 91-98. PMID: 30991306. DOI: 10.1016/j.jneuroim.2019.04.004.
13 Dubey D, Hinson SR, Jolliffe EA, et al. Autoimmune GFAP astrocytopathy: prospective evaluation of 90 patients in 1 year[J]. J Neuroimmunol, 2018, 321: 157-163. PMID: 29793728. DOI: 10.1016/j.jneuroim.2018.04.016.
14 Handoko M, Hong W, Espineli E, et al. Autoimmune glial fibrillary acidic protein astrocytopathy following herpes simplex virus encephalitis in a pediatric patient[J]. Pediatr Neurol, 2019, 98: 85-86. PMID: 31248671. DOI: 10.1016/j.pediatrneurol.2019.05.010.
15 Li J, Xu Y, Ren H, et al. Autoimmune GFAP astrocytopathy after viral encephalitis: a case report[J]. Mult Scler Relat Disord, 2018, 21: 84-87. PMID: 29499442. DOI: 10.1016/j.msard.2018.02.020.
16 Trau SP, Gallentine WB. Autoimmune GFAP-associated meningoencephalomyelitis: a report of a pediatric patient[J]. Pediatr Neurol, 2018, 82: 50. PMID: 29622490. DOI: 10.1016/j.pediatrneurol.2018.02.001.
17 Yang X, Xu H, Ding M, et al. Overlapping autoimmune syndromes in patients with glial fibrillary acidic protein antibodies[J]. Front Neurol, 2018, 9: 251. PMID: 29755396. PMCID: PMC5932346. DOI: 10.3389/fneur.2018.00251.
18 尹燕, 庄霞梅, 李晓明, 等. 自身免疫性胶质纤维酸性蛋白星形细胞病患者头颅磁共振成像特征分析[J]. 中国临床医学影像杂志, 2022, 33(2): 87-90. DOI: 10.12117/jccmi.2022.02.003.
19 徐辉明, 黄清梅, 肖小玉, 等. 自身免疫性胶质纤维酸性蛋白星形细胞病患者脊髓磁共振成像及临床特征分析[J]. 中华神经科杂志, 2019, 52(2): 92-97. DOI: 10.3760/cma.j.issn.1006-7876.2019.02.003.
20 黄莉, 李惠璐, 龙友明, 等. 自身免疫性胶质纤维酸性蛋白星型细胞病的脑电图特点[J]. 实用医学杂志, 2020, 36(19): 2700-2704. DOI: 10.3969/j.issn.1006-5725.2020.19.018.
21 Theroux LM, Goodkin HP, Heinan KC, et al. Extreme Delta brush and distinctive imaging in a pediatric patient with autoimmune GFAP astrocytopathy[J]. Mult Scler Relat Disord, 2018, 26: 121-123. PMID: 30245384. DOI: 10.1016/j.msard.2018.09.015.

PDF(698 KB)
HTML

Accesses

Citation

Detail

段落导航
相关文章

/